✦ LIBER ✦

Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma

✍ Scribed by Dennis S. Chi; Kristina McCaughty; John P. Diaz; Jae Huh; Sarah Schwabenbauer; Amanda J. Hummer; Ennapadam S. Venkatraman; Carol Aghajanian; Yukio Sonoda; Nadeem R. Abu-Rustum; Richard R. Barakat

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 146 KB
Volume: 106
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21845

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Secondary cytoreductive surgery in the m

Secondary cytoreductive surgery in the management of platinum-sensitive recurrent epithelial ovarian cancer

✍ Jeong-Yeol Park; Jeong-Min Eom; Dae-Yeon Kim; Jong-Hyeok Kim; Yong-Man Kim; Youn 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Secondary cytoreductive surgery for pati

Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: Who benefits?

✍ Rong-Yu Zang; Zi-Ting Li; Jie Tang; Xi Cheng; Shu-Mo Cai; Zhi-Yi Zhang; Nelson N 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 1 views

## Abstract ## BACKGROUND This study was performed to address patient selection criteria and the role of secondary cytoreductive surgery (SCR) in patients with epithelial ovarian carcinoma (EOC) who had relapsed tumors after a progression‐free interval ⩾ 3 months. ## METHODS One hundred seventee

The role of secondary cytoreductive surg

The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma

✍ Scott M. Eisenkop; Richard L. Friedman; Nick M. Spirtos 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 2 views

BACKGROUND. This study examined the impact of secondary cytoreductive surgery on survival of patients with recurrent epithelial ovarian carcinoma. ## METHODS. One hundred six patients with a disease free interval (DFI) Ͼ 6 months after primary treatment underwent secondary cytoreductive surgery. M

Surgery in recurrent epithelial ovarian

Surgery in recurrent epithelial ovarian cancer: Benefits on Survival for patients with residual disease of 0.1–1 cm after secondary cytoreduction

✍ Wen-Juan Tian; Rong Jiang; Xi Cheng; Jie Tang; Yan Xing; Rong-Yu Zang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 1 views

## Abstract ## Aims Recent retrospective trials stated that a benefit of surgery for recurrent ovarian cancer may be limited to patients in whom a complete cytoreduction (R0) could be achieved. Most of them pointed out there was no difference in survival between residual disease of 0.1–1 cm (R1) a